Financhill
Back

NexgenRx Quote, Financials, Valuation and Earnings

NexgenRx Price Quote

$0.26

NexgenRx Key Stats

Sell
22
NexgenRx (NXG.V) is a Sell

Day range:
$0.26 - $0.26
52-week range:
$0.18 - $0.35
Dividend yield:
3.85%
P/E ratio:
0.00
P/S ratio:
1.17
P/B ratio:
2.86%

Volume:
0
Avg. volume:
9.3K
1-year change:
10.64%
Market cap:
$18.5M
Revenue:
$13.8M
EPS:
$0

How Much Does NexgenRx Make?

  • How Much Are NexgenRx's Sales Annually?
    NXG.V Revenues are $13.8M
  • How Much Profit Does NexgenRx's Make A Year?
    NXG.V net income is -$332K

Is NexgenRx Growing As A Company?

  • What Is NexgenRx's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is NexgenRx's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

NexgenRx Stock Price Performance

  • Did NexgenRx Stock Go Up Last Month?
    NexgenRx share price went down by -11.86% last month
  • Did NXG.V's Share Price Rise Over The Last Year?
    NXG.V share price rose by 10.64% over the past 1 year

What Is NexgenRx 52-Week High & Low?

  • What Is NexgenRx’s 52-Week High Share Price?
    NexgenRx has traded as high as $0.35 over the past 52 weeks
  • What Is NexgenRx’s 52-Week Low Share Price?
    NexgenRx has traded as low as $0.18 over the past 52 weeks

NexgenRx Price To Free Cash Flow

  • Is NexgenRx Stock Overvalued?
    NexgenRx is trading at a price to free cash flow ratio of 17.44
  • Is NexgenRx Stock Undervalued?
    NexgenRx EV to Free Cash Flow ratio is 17.00
  • What Is NexgenRx’s Price Earnings Growth Ratio?
    NXG.V PEG ratio is 0.00
  • Is NexgenRx Trading At A Premium To Earnings?
    NexgenRx EV to EBIT ratio is 52.91

Is It Risky To Buy NexgenRx?

  • How Much Debt Does NexgenRx Have?
    Total long term debt quarterly is $0
  • How Much Cash Does NexgenRx Have?
    Cash and short term investments quarterly total is $1.8M
  • What Is NexgenRx’s Book Value Per Share?
    Book value per share is 0.09

Is NexgenRx Cash Flow Positive?

  • What Is NXG.V Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.3M
  • What Is NexgenRx’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.2M
  • What Is NexgenRx’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$230.3K

NexgenRx Return On Invested Capital

  • Is Management Doing A Good Job?
    NXG.V return on invested capital is 3.14%
  • What Is NexgenRx Return On Assets?
    ROA measures how assets are converting to revenues and is 0.84%
  • What Is NXG.V Return On Equity?
    ROE is a measure of profitability and is 3.14%

NexgenRx Earnings Date & Stock Price

  • What Is NexgenRx's Stock Price Today?
    A single share of NXG.V can be purchased today for 0.26
  • What Is NexgenRx’s Stock Symbol?
    NexgenRx trades on the tsxv under the ticker symbol: NXG.V
  • When Is NexgenRx’s Next Earnings Date?
    The next quarterly earnings date for NexgenRx is scheduled on December 11, 2024
  • When Is NXG.V's next ex-dividend date?
    NexgenRx's next ex-dividend date is December 16, 2024
  • How To Buy NexgenRx Stock?
    You can buy NexgenRx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

NexgenRx Competitors

  • Who Are NexgenRx's Competitors?
    Below is a list of companies who compete with NexgenRx or are related in some way:

NexgenRx Dividend Yield

  • What Is NXG.V Dividend Yield?
    NexgenRx’s dividend yield currently is 3.85%
  • What Is NexgenRx’s Payout Ratio?
    NexgenRx’s payout ratio is 494.23%
  • When Did NexgenRx Last Pay A Dividend?
    The latest dividend pay date is December 11, 2024
  • What Is NexgenRx’s Dividend Per Share?
    NexgenRx pays a dividend of $0.00 per share

NexgenRx Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 22.67% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable